HMGB1 and neoplasm: Overexpression of miR-665 in glioma cells inhibits tumor cell proliferation, migration, and invasion by targeting high mobility group box 1 (HMGB1) and High Mobility Group AT-hook 1 protein (HMGA1), deactivating the Wnt/β-catenin pathway [80].